Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FMWYP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,655
Award facts
- Contract value 100% obligated
- $14,654.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,654.74 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This firm fixed-price, competitively awarded contract was executed on July 31, 2025, with an ultimate completion date of August 1, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement that extends through December 2026 and supports pharmaceutical procurement for military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a key supplier for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Ozempic, a diabetes medication, represents one of numerous pharmaceutical product deliveries the contractor fulfills under its DLA framework, which encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The non-set-aside award reflects the contractor's demonstrated capability to meet federal procurement requirements through open competition within the broader context of DLA's Pharmaceutical Prime Vendor program.
Quick answers
Who was awarded contract SPE2DB25FMWYP?
SPE2DB25FMWYP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FMWYP worth?
The government has obligated $14,655 on SPE2DB25FMWYP.
Is contract SPE2DB25FMWYP an order under another contract?
Yes. SPE2DB25FMWYP is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMWYP competed?
The extent of competition for SPE2DB25FMWYP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award